These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 7480986)

  • 21. Interaction of inhaled beta 2 agonist and inhaled corticosteroid on airway responsiveness to allergen and methacholine.
    Cockcroft DW; Swystun VA; Bhagat R
    Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1485-9. PubMed ID: 7582281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Skin bruising in asthmatic subjects treated with high doses of inhaled steroids: frequency and association with adrenal function.
    Roy A; Leblanc C; Paquette L; Ghezzo H; Côté J; Cartíer A; Malo JL
    Eur Respir J; 1996 Feb; 9(2):226-31. PubMed ID: 8777956
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of early vs late intervention with inhaled corticosteroids in asthma.
    Selroos O; Pietinalho A; Löfroos AB; Riska H
    Chest; 1995 Nov; 108(5):1228-34. PubMed ID: 7587421
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effectiveness and safety of montelukast versus budesonide at various doses on bronchial reactivity in subjects with mild persistent asthma].
    Riccioni G; D'Orazio N; Di Ilio C; Della Vecchia R; De Lorenzo A
    Clin Ter; 2002; 153(5):317-21. PubMed ID: 12510415
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids.
    Hanania NA; Chapman KR; Sturtridge WC; Szalai JP; Kesten S
    J Allergy Clin Immunol; 1995 Nov; 96(5 Pt 1):571-9. PubMed ID: 7499672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does ketotifen have a steroid-sparing effect in childhood asthma?
    Canny GJ; Reisman J; Levison H
    Eur Respir J; 1997 Jan; 10(1):65-70. PubMed ID: 9032494
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An inhaled glucocorticoid does not prevent tolerance to the bronchoprotective effect of a long-acting inhaled beta 2-agonist.
    Yates DH; Kharitonov SA; Barnes PJ
    Am J Respir Crit Care Med; 1996 Dec; 154(6 Pt 1):1603-7. PubMed ID: 8970342
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
    Wong CS; Wahedna I; Pavord ID; Tattersfield AE
    Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1268-73. PubMed ID: 7952551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of inhaled budesonide on seasonal changes in sensitivity and maximal response to methacholine in pollen-sensitive asthmatic subjects.
    Prieto L; Bertó JM; Gutiérrez V; Tornero C
    Eur Respir J; 1994 Oct; 7(10):1845-51. PubMed ID: 7828695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children.
    Agertoft L; Pedersen S
    Respir Med; 1994 May; 88(5):373-81. PubMed ID: 8036306
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids.
    Jónasson G; Carlsen KH; Blomqvist P
    Eur Respir J; 1998 Nov; 12(5):1099-104. PubMed ID: 9864004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1.6 mg daily, in patients with chronic severe asthma. International Study Group.
    Ayres JG; Bateman ED; Lundbäck B; Harris TA
    Eur Respir J; 1995 Apr; 8(4):579-86. PubMed ID: 7664857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma.
    Kuna P; Creemers JP; Vondra V; Black PN; Lindqvist A; Nihlen U; Vogelmeier C
    Respir Med; 2006 Dec; 100(12):2151-9. PubMed ID: 16701989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Knemometric assessment of systemic activity of once daily intranasal dry-powder budesonide in children.
    Wolthers OD; Pedersen S
    Allergy; 1994 Feb; 49(2):96-9. PubMed ID: 8172365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multinational, 12-week, randomized study comparing the efficacy and tolerability of ciclesonide and budesonide in patients with asthma.
    Hansel TT; Benezet O; Kafé H; Ponitz HH; Cheung D; Engelstätter R; Barnes PJ
    Clin Ther; 2006 Jun; 28(6):906-20. PubMed ID: 16860173
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients.
    Clark DJ; Lipworth BJ
    Thorax; 1997 Jan; 52(1):55-8. PubMed ID: 9039246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maximal response plateau to methacholine as a reliable index for reducing inhaled budesonide in moderate asthma.
    Prieto L; Gutiérrez V; Morales C
    Eur Respir J; 1999 Jun; 13(6):1236-44. PubMed ID: 10445596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of inhaled corticosteroids on the maximal degree of airway narrowing to methacholine in asthmatic subjects.
    Bel EH; Timmers MC; Zwinderman AH; Dijkman JH; Sterk PJ
    Am Rev Respir Dis; 1991 Jan; 143(1):109-13. PubMed ID: 1986667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of budesonide inhalation suspension in infants and young children with persistent asthma. Budesonide Inhalation Suspension Study Group.
    Mellon M
    J Allergy Clin Immunol; 1999 Oct; 104(4 Pt 2):191-9. PubMed ID: 10518846
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenal suppression with inhaled budesonide and fluticasone propionate given by large volume spacer to asthmatic children.
    Clark DJ; Clark RA; Lipworth BJ
    Thorax; 1996 Sep; 51(9):941-3. PubMed ID: 8984708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.